Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Queensland Health
Colorcon
US Army
Citi
Cipla
Chubb
Cerilliant

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009866

« Back to Dashboard

NDA 009866 describes SOLU-CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the SOLU-CORTEF profile page.

The generic ingredient in SOLU-CORTEF is hydrocortisone sodium succinate. There are sixty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
Summary for 009866
Pharmacology for NDA: 009866
Suppliers and Packaging for NDA: 009866
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866 NDA Pharmacia and Upjohn Company LLC 0009-0005 N 0009-0005-01
SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866 NDA Pharmacia and Upjohn Company LLC 0009-0011 N 0009-0011-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 250MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
McKinsey
Dow
Harvard Business School
Deloitte
Fuji
Medtronic
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.